Sequence variability of the integrase protein from a diverse collection of HIV type 1 isolates representing several subtypes

被引:17
|
作者
Burns, CC [1 ]
Gleason, LM
Mozaffarian, A
Giachetti, C
Carr, JK
Overbaugh, J
机构
[1] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA
[2] Gen Probe, San Diego, CA 92121 USA
[3] Henry M Jackson Fdn, Rockville, MD 20850 USA
关键词
D O I
10.1089/08892220260235399
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV-1 recombinants between viruses from different subtypes appear to be surprisingly common in several regions of the world. To detect such intersubtype recombinants that contain mosaic genomes, we have analyzed sequences from the integrase (IN)-coding region of the polymerase (pol) gene from 23 viruses of known envelope (env) subtype from South America and Africa. As defined by env sequences, these viral genomes included nine subtype A, four subtype B, three subtype C, and four subtype D viruses from group M, and three viruses from group O HIV-1. Mosaic genomes were common, with 7 mosaic genomes among the 20 group M isolates analyzed. Two of these isolates had mosaic IN-coding regions that were distinct, but that had recombination breakpoints at the same location, in the highly conserved polypurine track. Mosaic genomes were particularly common in the viruses from Kenya (five of nine), consistent with our previous prediction that there was a high frequency of intersubtype recombinants circulating in this country. The IN amino acid sequence was highly conserved among the several represented subtypes, including group O. Group M IN sequences shared 94% or greater amino acid sequence identity within a subtype and 91% or greater identity between subtypes. The most divergent M and O variant amino acid sequences differed by only 19%, and the known functional domains were conserved among all of the isolates. The high degree of genetic homogeneity among the virus isolates representing several subtypes indicates that a single drug targeted against IN might be effective for all HIV-1 infections.
引用
收藏
页码:1031 / 1041
页数:11
相关论文
共 50 条
  • [31] Efficacy of MK-8591 against diverse HIV-1 subtypes and NRTI-resistant clinical isolates
    Grobler, J.
    Huang, Q.
    Hazuda, D.
    Lai, M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [32] Genetic variability of HIV-1 isolates from Minas Gerais, Brazil
    Proietti, ABDC
    Barbosa, EF
    Silva, JG
    de Carvalho, AF
    Kroon, EG
    Ferreira, PCP
    REVISTA DE MICROBIOLOGIA, 1999, 30 (02): : 141 - 143
  • [33] NEUTRALIZATION LOOP VARIABILITY IN HIV-1 ISOLATES FROM THE KINSHASA AREA
    GUO, HG
    ZAGURY, D
    WATERS, D
    FITZGIBBON, J
    DUBIN, D
    SALAUN, J
    LURHUMA, A
    WONGSTAAL, F
    MYERS, G
    GALLO, RC
    REITZ, M
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (01) : 33 - 33
  • [34] NEUTRALIZATION OF PRIMARY FIELD ISOLATES OF HIV-1 FROM GLOBALLY DIVERSE CLADES
    POTTS, BJ
    FIELD, K
    MASCOLA, J
    WANG, CY
    KOFF, W
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S56 - S56
  • [35] Comparison of Vpu sequences from diverse geographical isolates of HIV type 1 identifies the presence of highly variable domains, additional invariant amino acids, and a signature sequence motif common to subtype C isolates
    McCormick-Davis, C
    Dalton, SB
    Singh, DK
    Stephens, EB
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (11) : 1089 - 1095
  • [36] Impact of Integrase Sequences from HIV-1 Subtypes A6/A1 on the In Vitro Potency of Cabotegravir or Rilpivirine
    Jeffrey, Jerry L.
    St Clair, Marty
    Wang, Ping
    Wang, Chunfu
    Li, Zhufang
    Beloor, Jagadish
    Talarico, Christine
    Fridell, Robert
    Krystal, Mark
    White, C. Thomas
    Griffith, Sandy
    D'Amico, Ronald
    Smith, Kimberly
    Van Eygen, Veerle
    Vingerhoets, Johan
    Vandermeulen, Kati
    Spreen, William
    van Lunzen, Jan
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (03)
  • [37] Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes
    Maiga, Almoustapha-Issiaka
    Malet, Isabelle
    Soulie, Cathia
    Derache, Anne
    Koita, Victoria
    Amellal, Bahia
    Tchertanov, Luba
    Delelis, Olivier
    Morand-Joubert, Laurence
    Mouscadet, Jean-Francois
    Murphy, Robert
    Cisse, Mamadou
    Katlama, Christine
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    ANTIVIRAL THERAPY, 2009, 14 (01) : 123 - 129
  • [38] LIMITED SEQUENCE DIVERSITY OF THE HIV TYPE-1 PROTEASE GENE FROM CLINICAL ISOLATES AND IN-VITRO SUSCEPTIBILITY TO HIV PROTEASE INHIBITORS
    WINSLOW, DL
    STACK, S
    KING, R
    SCARNATI, H
    BINCSIK, A
    OTTO, MJ
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (01) : 107 - 113
  • [39] env gene diversity of HIV type 1 isolates from Spain
    QuinonesMateu, ME
    Holguin, A
    Soriano, V
    Domingo, E
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (10) : 955 - 957
  • [40] Sequence analyses of the reverse transcriptase region of HIV type I isolates from Sydney, Australia
    Zheng, NN
    Hurren, L
    Neilan, BA
    Cooper, DA
    Delaney, SF
    McQueen, PW
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (18) : 1731 - 1732